Small Molecule Neuropilin-1 Antagonists Combine Antiangiogenic and Antitumor Activity with Immune Modulation through Reduction of Transforming Growth Factor Beta (TGFβ) Production in Regulatory T-Cells

[Image: see text] We report the design, synthesis, and biological evaluation of some potent small-molecule neuropilin-1 (NRP1) antagonists. NRP1 is implicated in the immune response to tumors, particularly in Treg cell fragility, required for PD1 checkpoint blockade. The design of these compounds wa...

Descripción completa

Detalles Bibliográficos
Autores principales: Powell, Jonathan, Mota, Filipa, Steadman, David, Soudy, Christelle, Miyauchi, Jeremy T., Crosby, Stuart, Jarvis, Ashley, Reisinger, Tifelle, Winfield, Natalie, Evans, Graham, Finniear, Aled, Yelland, Tamas, Chou, Yi-Tai, Chan, A.W. Edith, O’Leary, Andrew, Cheng, Lili, Liu, Dan, Fotinou, Constantina, Milagre, Carla, Martin, John F., Jia, Haiyan, Frankel, Paul, Djordjevic, Snezana, Tsirka, Stella E., Zachary, Ian C, Selwood, David L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Chemical Society 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957473/
https://www.ncbi.nlm.nih.gov/pubmed/29648813
http://dx.doi.org/10.1021/acs.jmedchem.8b00210

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5957473/
https://www.ncbi.nlm.nih.gov/pubmed/29648813
http://dx.doi.org/10.1021/acs.jmedchem.8b00210

Ejemplares similares